Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

Clinical trial NCT00067041 · TERMINATED

Trial details

NCT number: NCT00067041
Sponsor: United Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peripheral Vascular Disease

Start date: 2003-03-01
Primary completion: 2003-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.